Amgen
Search results
Gilead Sciences, Inc. (/ ˈ ɡ ɪ l i ə d /) is an American biopharmaceutical company headquartered in Foster City, California that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.
- US$4.59 billion (2022)
- Foster City, California, United States
- c. 17,000 (2022)
- US$27.28 billion (2022)
Mar 21, 2024 · Access and Health Equity. Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.
About Us. At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine.
People also ask
Who is Gilead Sciences?
Is Gilead a biopharmaceutical company?
Who is the CEO of Gilead Sciences?
What does Gilead do?
Company Overview. Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. With each new discovery and investigational drug candidate, we seek to improve the care of patients living with life-threatening diseases around the world.
- 782KB
- 7
Company History: Gilead Sciences, Inc. is a biotechnology company specializing in developing and marketing drugs to treat antiviral diseases. Gilead's primary focus is in developing treatments for the human immunodeficiency virus (HIV), a virus that causes acquired immune deficiency syndrome (AIDS) and infections related to AIDS.
John Charles Martin (May 7, 1951 – March 30, 2021) was an American billionaire businessman, and the former executive chairman (2016–2018) and CEO (1996–2016) of the American biotechnology company Gilead Sciences. He joined Gilead Sciences in 1990 as vice president for research and development.
Last updated February 25, 2024. Gilead Sciences, Inc. Headquarters in Foster City. Company type. Public. Traded as. Nasdaq: GILD. Nasdaq Biotechnology component. Nasdaq-100 component. S&P 100 component. S&P 500 component. Industry. Pharmaceutics. Biotechnology. Founded. June 22, 1987;36 years ago1987-06-22. Headquarters.
